Cleared Traditional

CrossFAST™ Integrated Microcatheter Guide Extension System (CFM55) (K242276) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242276 · Vantis Vascular, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2024
Decision
60d
Days
Class 2
Risk

K242276 is an FDA 510(k) clearance for the CrossFAST™ Integrated Microcatheter Guide Extension System (CFM55). Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Vantis Vascular, Inc. (San Jose, US). The FDA issued a Cleared decision on September 30, 2024 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vantis Vascular, Inc. devices

Submission Details

510(k) Number K242276 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2024
Decision Date September 30, 2024
Days to Decision 60 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 125d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 317
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K242276.
SENDERO MAX Delivery Catheter
K242644 · Okami Medical, Inc. · Dec 2024
Shadow Catheter
K240885 · Simpson Interventions, Inc. · Dec 2024
SSPC NXT Delivery Catheter
K243180 · CenterPoint Systems, LLC · Dec 2024
Selectra 3D Lead Delivery System (443624-443629, 451789-451791)
K240787 · Biotronik, Inc. · Sep 2024
ShapeIT (SI014135)
K241611 · Imds Operations B.V. · Sep 2024
TriClip Steerable Guide Catheter
K241538 · Abbott Medical · Aug 2024